Quarterly report [Sections 13 or 15(d)]

Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)

v3.26.3
Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Share-Based Payment Arrangement [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants to purchase common stock 24,963 30,481 24,963 30,481
Convertible Debt Securities [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants to purchase common stock 523,048 358,931 523,048 358,931
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants to purchase common stock 835,584 757,521 835,584 757,521